新治疗策略与儿童溃疡性结肠炎结肠切除率显著下降相关
基于EPIMAD登记队列,纳入1988至2011年诊断的337例儿童起病溃疡性结肠炎患者,回顾性随访至2013年。按诊断时期分为3期,比较免疫抑制剂和抗TNF暴露及疾病结局。结果显示5年结肠切除风险从P1的17%降至P3的9%,但复发相关住院风险从16%升至42%。
要点
- 儿童起病溃疡性结肠炎5年结肠切除风险从P1的17%降至P3的9%。
- 5年免疫抑制剂暴露率从P1的7.8%升至P3的63.8%,抗TNF从0%升至37.2%。
- 5年复发相关住院风险从P1的16%升至P3的42%,疾病扩展风险无显著变化。
核心结论
- 在儿童起病溃疡性结肠炎中,伴随免疫抑制剂和抗TNF使用增加,人群水平观察到结肠切除风险显著下降。
研究设计与样本
- 基于EPIMAD登记队列的回顾性随访研究,纳入1988至2011年间诊断的337例儿童起病溃疡性结肠炎患者,随访至2013年。
- 按诊断时期分为3期:1988至1993年(P1,免疫抑制剂前时代)、1994至2000年(P2,抗TNF前时代)和2001至2011年(P3,抗TNF时代)。
主要发现
- 5年免疫抑制剂暴露率从P1的7.8%升至P3的63.8%,5年抗TNF暴露率从P1的0%升至P3的37.2%。
- 5年结肠切除风险从P1的17%、P2的19%降至P3的9%(P=0.045,P-trend=0.027);抗TNF前时代(P1+P2)为18%,抗TNF时代(P3)为9%(P=0.013)。
- 5年疾病扩展风险P1为36%、P2为32%、P3为34%(P=0.31,P-trend=0.52);抗TNF前时代(P1+P2)为34%,抗TNF时代(P3)为34%(P=0.92)。
- 5年复发相关住院风险从P1的16%、P2的27%升至P3的42%(P=0.0012,P-trend=0.0006);抗TNF前时代(P1+P2)为23%,抗TNF时代(P3)为42%(P=0.0004)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: We evaluated the impact of immunosuppressants (IS) and antitumor necrosis factor (TNF) introduction on long-term outcomes of ulcerative colitis (UC) in a large population-based pediatric-onset cohort. METHODS: All patients included in the EPIMAD registry with a diagnosis of UC made before the age of 17 years between 1988 and 2011 were followed up retrospectively until 2013. Medication exposure and disease outcomes were compared between 3 diagnostic periods: 1988 to 1993 (period [P] 1; pre-IS era), 1994 to 2000 (P2; pre-anti-TNF era), and 2001 to 2011 (P3; anti-TNF era). RESULTS: A total of 337 patients (female, 57%) diagnosed with UC were followed up during a median duration of 7.2 years (interquartile range 3.8-13.0). The IS and anti-TNF exposure rates at 5 years increased over time from 7.8% (P1) to 63.8% (P3) and from 0% (P1) to 37.2% (P3), respectively. In parallel, the risk of colectomy at 5 years decreased significantly over time (P1, 17%; P2, 19%; and P3, 9%; P = 0.045, P -trend = 0.027) and between the pre-anti-TNF era (P1 + P2, 18%) and the anti-TNF era (P3, 9%) ( P = 0.013). The risk of disease extension at 5 years remained stable over time (P1, 36%, P2, 32%, and P3, 34%; P = 0.31, P -trend = 0.52) and between the pre-anti-TNF era (P1 + P2, 34%) and the anti-TNF era (P3, 34%) ( P = 0.92). The risk of flare-related hospitalization at 5 years significantly increased over time (P1, 16%; P2, 27%; P3, 42%; P = 0.0012, P -trend = 0.0006) and between the pre-anti-TNF era (P1 + P2, 23%) and the anti-TNF era (P3, 42%) ( P = 0.0004). DISCUSSION: In parallel with the increased use of IS and anti-TNF, an important decline in the risk of colectomy in pediatric-onset UC was observed at the population level.
引用
- Ley D, Leroyer A, Dupont C, et al. New Therapeutic Strategies Are Associated With a Significant Decrease in Colectomy Rate in Pediatric Ulcerative Colitis. Am J Gastroenterol. 2023. PMID: 37141541. doi:10.14309/ajg.0000000000002316
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。